MedPath

ong-Term Extension Study of Nusinersen in Participants With SMA

Phase 3
Conditions
Spinal muscular atrophy
Registration Number
JPRN-jRCT2031220035
Lead Sponsor
Irzhevsky Victoria
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
172
Inclusion Criteria

Completion of the Day 302 Visit in Study 203 and compliance with the study protocol throughout Study 203.

Exclusion Criteria

- Treatment with another investigational therapy or enrollment in another interventional clinical study.

- Treatment with an approved therapy for SMA after the Day 302 Visit of Study 203.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
- Incidence of AEs, including SAE<br><br>- Change in growth parameters<br><br>- Shifts from baseline in clinical laboratory parameters, ECGs, and vital signs<br><br>- Shifts from baseline in coagulation parameters (aPTT, PT, and INR)<br><br>- Change in urine total protein<br><br>- Change from baseline in neurological examination outcomes<br><br>- The proportion of participants with a postbaseline platelet count below the lower limit of normal on at least 2 consecutive measurements<br><br>- The proportion of participants with a postbaseline QTcF of > 500 msec and an increase from baseline to any postbaseline timepoint in QTcF of > 60 msec
Secondary Outcome Measures
NameTimeMethod
- Total number of new WHO motor milestones<br><br>- Ventilator use<br><br>- Time to death (overall survival)<br><br>- Change from baseline in CHOP INTEND total score<br><br>- Change from baseline in HINE Section 2 motor milestones<br><br>- Proportion of HINE Section 2 motor milestone responders<br><br>- Proportion of time on ventilation<br><br>- Time to death or permanent ventilation (tracheostomyor >= 16 hours of ventilation/day continuously for >21 days in the absence of an acute reversible event)<br><br>- Change from baseline in HFMSE score<br><br>- Change from baseline in RULM score
© Copyright 2025. All Rights Reserved by MedPath